ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;85:1837-1838. doi:10.1016/j.athoracsur.2006.09.079
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jack A. Roth
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Roth, J. A.
PubMed
Right arrow Articles by Roth, J. A.
Related Collections
Right arrow Esophagus - cancer
Right arrow Lung - cancer
Right arrow Molecular biology


Key References

Gene Therapy in Thoracic Oncology

Jack A. Roth, MD*

University of Texas MD Anderson Cancer Center, Department of Thoracic and Cardiovascular Surgery, Houston, Texas

* Address correspondence to Dr Roth, University of Texas MD Anderson Cancer Center, Department of Thoracic and Cardiovascular Surgery, PO Box 301402, Unit 445, Houston, TX 77230-1402 (Email: jroth@mdanderson.org).


    Gene Therapy for Lung Cancer
 

1 Nguyen DM, Spitz FR, Yen N, Cristiano RJ, Roth JA. Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. J Thorac Cardiovasc Surg 1996;112:1372–6.
2 Claudio PP, Howard CM, Pacilio C, et al. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res 2000;60:372–82.
3 Inoue A, Narumi K, Matsubara N, et al. Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene. Cancer Lett 2000;157:105–12.
4 Heike Y, Takahashi M, Kanegae Y, Sato Y, Saito I, Saijo N. Interleukin-2 gene transduction into freshly isolated lung adenocarcinoma cells with adenoviral vectors. Hum Gene Ther 1997;8:1–14.
5 Dubinett SM, Miller PW, Sharma S, Batra RK. Gene therapy for lung cancer. Hematol Oncol Clin North Am 1998;12:569–94.
6 Albelda SM. Gene therapy for lung cancer and mesothelioma. Chest 1997;111:S144–9.
7 Miller PW, Sharma S, Stolina M, et al. Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer. Cancer Gene Ther 1998;5:380–9.
8 Moon C, Oh Y, Roth JA. Current status of gene therapy for lung cancer and head and neck cancer. Clinic Cancer Res 2003;9:5055–67.
9 Batra RK, Olsen JC, Pickles RJ, Hoganson DK, Boucher RC. Transduction of non-small cell lung cancer cells by adenoviral and retroviral vectors. Am J Respir Cell Mol Biol 1998;18:402–10.
10 Frederiksen KS, Petri A, Abrahamsen N, Poulsen HS. Gene therapy for lung cancer. Lung Cancer 1999;23:191–207.
11 Gopalan B, Ito I, Branch CD, Stephens C, Roth . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.